78 related articles for article (PubMed ID: 1578168)
1. Fecal alpha-1-antitrypsin concentration in patients with schistosomal hepatic fibrosis.
el Aggan HA; Marzouk S
J Egypt Soc Parasitol; 1992 Apr; 22(1):195-203. PubMed ID: 1578168
[TBL] [Abstract][Full Text] [Related]
2. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
Schwery S; Meyenberger C; Ammann R; Wirth HP
Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
[TBL] [Abstract][Full Text] [Related]
3. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
Hundegger K; Stufler M; Karbach U
Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
[TBL] [Abstract][Full Text] [Related]
4. Protein-losing enteropathy in congestive cardiac failure: an entity of minor clinical significance.
Berkowitz I; Segal I
Am J Gastroenterol; 1990 Feb; 85(2):154-6. PubMed ID: 2301337
[TBL] [Abstract][Full Text] [Related]
5. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
Thomas DW; Sinatra FR; Merritt RJ
Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
[TBL] [Abstract][Full Text] [Related]
6. [Increased serum alpha 1-antitrypsin does not produce a rise in fecal alpha 1-antitrypsin in patients with healthy intestines].
Stufler MH; Ewe K; Gierlasinski B; Prün H; Zutt M
Z Gastroenterol; 1991 Jan; 29(1):11-5. PubMed ID: 2058223
[TBL] [Abstract][Full Text] [Related]
7. [Alpha 1-antitrypsin as an endogenous marker of protein-losing enteropathies].
Kulesza E; Lisowska B; Tomaszewski L; Dobrowolski W; Socha J
Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):98-101. PubMed ID: 1437795
[TBL] [Abstract][Full Text] [Related]
8. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations.
Fujii T; Shimizu T; Takahashi K; Kishiro M; Ohkubo M; Akimoto K; Yamashiro Y
J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):577-80. PubMed ID: 14581800
[TBL] [Abstract][Full Text] [Related]
9. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease.
Elsammak MY; Al-Sharkaweey RM; Ragab MS; Amin GA; Kandil MH
Parasite Immunol; 2008; 30(11-12):603-9. PubMed ID: 19067841
[TBL] [Abstract][Full Text] [Related]
10. Protein-losing enteropathy and hypoalbuminemia in AIDS.
Laine L; Garcia F; McGilligan K; Malinko A; Sinatra FR; Thomas DW
AIDS; 1993 Jun; 7(6):837-40. PubMed ID: 8363760
[TBL] [Abstract][Full Text] [Related]
11. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of protein-losing enteropathy in pediatric patients].
Sierra Salinas C; Vicioso Recio MI; Barco Galvez A; del Rio Mapelli L; Martinez Valverde A
An Esp Pediatr; 1997 Aug; 47(2):144-50. PubMed ID: 9382345
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 antitrypsin and electrolytes in some cases of diarrhoea.
el-Hawy AM; Abou-Taleb SA; Massoud AM; Abdel-Khalek YH
J Egypt Soc Parasitol; 1989 Jun; 19(1):131-7. PubMed ID: 2785149
[TBL] [Abstract][Full Text] [Related]
14. Selective intestinal decontamination in patients with schistosomal hepatic fibrosis and low-protein ascites.
el Aggan HA; el-Aggan HA; Abou Seif Helmy M; Guirguis TG
J Egypt Soc Parasitol; 1993 Dec; 23(3):649-57. PubMed ID: 8308339
[TBL] [Abstract][Full Text] [Related]
15. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea.
Duarte MA; Carneiro SM; Melo MC; Penna FJ
Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022
[TBL] [Abstract][Full Text] [Related]
16. Enteric protein loss during shigellosis.
Bennish ML; Salam MA; Wahed MA
Am J Gastroenterol; 1993 Jan; 88(1):53-7. PubMed ID: 8420274
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis.
Chang D; Ramalho LN; Ramalho FS; Martinelli AL; Zucoloto S
Acta Trop; 2006 Mar; 97(3):318-23. PubMed ID: 16473318
[TBL] [Abstract][Full Text] [Related]
18. Protein losing enteropathy as the initial manifestation of childhood systemic lupus erythematosus.
Molina JF; Brown RF; Gedalia A; Espinoza LR
J Rheumatol; 1996 Jul; 23(7):1269-71. PubMed ID: 8823704
[TBL] [Abstract][Full Text] [Related]
19. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance.
Karbach U; Ewe K
Z Gastroenterol; 1989 Jul; 27(7):362-5. PubMed ID: 2475983
[TBL] [Abstract][Full Text] [Related]
20. Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis.
Assaad-Khalil SH; Lachine N; Sidrak M; Amara F; Jacotot B; Fahmy MH
Ann Biol Clin (Paris); 1992; 50(10-11):697-701. PubMed ID: 1306953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
